Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Janssen Pharmaceuticals)"
Count: 2301
Selected: 0
| NCT ID | Title |
|---|
| NCT03915886 | A Study of JNJ-64530440 in Healthy Japanese Male Participants | ||
| NCT02342249 | Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects | ||
| NCT00207688 | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | ||
| NCT01026376 | An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS) | ||
| NCT05567185 | A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer | ||
| NCT05242432 | A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants | ||
| NCT05167825 | A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension | ||
| NCT05159128 | A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants | ||
| NCT05062200 | A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants | ||
| NCT05039710 | A Study of JNJ-75220795 in Japanese Participants | ||
| NCT04963725 | A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice | ||
| NCT04945733 | A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer | ||
| NCT04882072 | A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) | ||
| NCT04868916 | An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa | ||
| NCT04791332 | A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants | ||
| NCT04773522 | A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04713930 | A Study of JNJ-61393215 in Healthy Japanese Male Participants | ||
| NCT04696809 | A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04683029 | A Study of Guselkumab in Participants With Systemic Sclerosis | ||
| NCT04677530 | A Study of JNJ-40411813 in Healthy Japanese Male Participants | ||
| NCT04630145 | A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) | ||
| NCT04509947 | A Study of Ad26.COV2.S in Adults (COVID-19) | ||
| NCT04500808 | A Study of Macitentan, in Healthy Japanese Male Participants | ||
| NCT04459507 | A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan | ||
| NCT04397263 | A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT04354480 | A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older | ||
| NCT04325828 | A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma | ||
| NCT04306302 | A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults | ||
| NCT04241549 | A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment | ||
| NCT04062448 | A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM) | ||
| NCT04034095 | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | ||
| NCT03981744 | A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments | ||
| NCT03689153 | A Study of JNJ-63733657 in Healthy Japanese Participants | ||
| NCT03618160 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants | ||
| NCT03547037 | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers | ||
| NCT03536325 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants | ||
| NCT03474679 | A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD) | ||
| NCT03398876 | A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers | ||
| NCT03242889 | A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT03123848 | A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants | ||
| NCT03002025 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants | ||
| NCT02993250 | A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive | ||
| NCT02918331 | A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation | ||
| NCT02918318 | A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression | ||
| NCT02895815 | Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) | ||
| NCT02835508 | Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants | ||
| NCT02748967 | A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants | ||
| NCT02641730 | An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis | ||
| NCT02556892 | A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT02555124 | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants |
